Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
217 hedge funds and large institutions have $1,000M invested in Immunogen Inc in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 78 reducing their positions, and 22 closing their positions.
160% more call options, than puts
Call options by funds: $17M | Put options by funds: $6.54M
27% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 22
1% more funds holding
Funds holding: 214 → 217 (+3)
16% less capital invested
Capital invested by funds: $1.18B → $1,000M (-$184M)
24% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 78
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$11.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.33M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.13M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.92M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$9.56M |
| 2 |
Renaissance Technologies
New York
|
-$5.44M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$5.2M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.94M |
| 5 |
Two Sigma Advisers
New York
|
-$4.78M |
IMGN Hedge Fund Activity: Q3 2021 in Review
217 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2021, worth a combined $1,000M — down 16% from $1.18B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new IMGN positions and 22 closed out — a net gain of 6 holders — while 59 added to existing stakes and 78 trimmed.
The largest buyer was OrbiMed, adding an estimated $11.3M. The largest seller was State Street, cutting an estimated $9.56M.
- 217 institutional investors held Immunogen Inc (IMGN) as of Q3 2021, up from 214 in Q2 2021.
- Funds reported $1,000M of Immunogen Inc stock for Q3 2021, down 16% quarter-over-quarter.
- 28 funds opened new Immunogen Inc positions in Q3 2021 and 22 closed out, a net change of +6 holders.
- The largest Immunogen Inc buyer in Q3 2021 was OrbiMed, an estimated $11.3M added.
- The largest Immunogen Inc seller in Q3 2021 was State Street, an estimated $9.56M sold.
Based on aggregated 13F filings for Q3 2021.